Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 3/20 | 0.35 |
| ▸ | CCL2 | P13500 | 2/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | GSK3A | P49840 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL200674 | 0.73 | MAPT (0.41) | ADRA2CGSK3AGSK3BMGLLKMT2A | |
| SCHEMBL1263023 | 0.71 | MAPT (0.40) | ADRA2CGSK3AGSK3BMGLLKMT2A | |
| SCHEMBL4006398 | 0.71 | MAPT (0.40) | ADRA2CGSK3AGSK3BMGLLKMT2A | |
| SCHEMBL1263355 | 0.71 | MAPT (0.40) | ADRA2CGSK3AGSK3BMGLLKMT2A | |
| Calcium SCHEMBL30891545 | 0.71 | MAPT (0.40) | ADRA2CGSK3AGSK3BMGLLKMT2A | |
| SCHEMBL9612339 | 0.69 | MEN1 (0.35) | KMT2AMEN1BLM | |
| SCHEMBL3267916 | 0.69 | MEN1 (0.35) | GSK3AGSK3BKMT2AMEN1BLM | |
| SCHEMBL13804707 | 0.67 | MEN1 (0.38) | ADRA2CGSK3AGSK3BMGLLKMT2A | |
| SCHEMBL13710838 | 0.65 | — | — | |
| SCHEMBL106970 | 0.64 | ADRA2C (0.35) | ADRA2CGSK3AGSK3BMGLLKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170325459-A1 | BICYCLIC COMPOUNDS AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170325459-A1 | BICYCLIC COMPOUNDS AS PEST CONTROL AGENTS | DDT, BCHE, BAK1 | BRD4 284/4885CCL2 1947/4885ADRA2C 478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.